286 related articles for article (PubMed ID: 16675299)
1. Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART).
Steininger C; Puchhammer-Stöckl E; Popow-Kraupp T
J Clin Virol; 2006 Sep; 37(1):1-9. PubMed ID: 16675299
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
3. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
4. [CMV infection in HIV-infected patients].
Podlasin RB
Przegl Epidemiol; 2007; 61(4):629-37. PubMed ID: 18572494
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in cytomegalovirus disease in HIV-infected patients.
Deayton JR
Herpes; 2001 Jul; 8(2):37-40. PubMed ID: 11867016
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity.
Springer KL; Weinberg A
J Antimicrob Chemother; 2004 Sep; 54(3):582-6. PubMed ID: 15282241
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis of cytomegalovirus (CMV) infections in immunodepressed patients, mainly in patients with AIDS.
Tendero DT
Clin Lab; 2001; 47(3-4):169-83. PubMed ID: 11294581
[TBL] [Abstract][Full Text] [Related]
12. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
[TBL] [Abstract][Full Text] [Related]
13. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.
Para MF; Kalish LA; Collier AC; Murphy EL; Drew WL;
J Infect Dis; 2001 Jun; 183(11):1673-7. PubMed ID: 11343218
[TBL] [Abstract][Full Text] [Related]
14. CMV as a cofactor enhancing progression of AIDS.
Griffiths PD
J Clin Virol; 2006 Apr; 35(4):489-92. PubMed ID: 16413825
[TBL] [Abstract][Full Text] [Related]
15. CMV PCR in leucocytes as an early marker for the development of CMV disease in AIDS patients.
Quarner H; Grützmeier S; Lewensohn-Fuchs I; Hejdeman B; Sandström E; Ehrnst A
Scand J Infect Dis Suppl; 1995; 99():94-5. PubMed ID: 8668950
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utility.
Edwards SG; Grover D; Scott C; Tedder RS; Pillay D; Copas A; Miller RF
Int J STD AIDS; 2007 May; 18(5):321-3. PubMed ID: 17524192
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
18. [The diagnosis and clinical characteristics of cytomegalovirus infection in HIV-infected subjects].
Shakhgil'dian VI; Kravchenko AV; Shipulina OIu; Marchenko NR; Ermak TN; Iurin OG; Stakhanova VM; Parkhomenko IuG; Karazhas NV; Evseeva LF; Gruzdev BM; Pokrovskiĭ VV
Ter Arkh; 1996; 68(4):65-8. PubMed ID: 9324798
[TBL] [Abstract][Full Text] [Related]
19. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
[TBL] [Abstract][Full Text] [Related]
20. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.
Deayton JR; Prof Sabin CA; Johnson MA; Emery VC; Wilson P; Griffiths PD
Lancet; 2004 Jun; 363(9427):2116-21. PubMed ID: 15220032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
